0
ARTICLE |

Epitopes in Medicine: Title and subTitle BreakThe Example of the Lupus Anticoagulant FREE

J. David Bessman, MD
JAMA. 1988;259(4):573-573. doi:10.1001/jama.1988.03720040065031
Text Size: A A A
Published online

In this issue of The Journal, Triplett et al1 discuss the relationship among an established laboratory test (lupus anticoagulant), an experimental laboratory test (anticardiolipin antibody), and a clinical phenomenon (thrombosis). To understand the conclusion of their work, a little background is needed. They observe that the target of the anticardiolipin assay may be an "epitope" of the lupus anticoagulant. An epitope (from the Greek word for "nearby place") is an antigenic determinant, a structure that can be identified by an antibody. However, the antigenic determinant may be unrelated except by proximity, not by cause, to some other structure of interest.

See also p 550.

Why the interest in epitopes? There is rapidly increasing interest in using specific antibodies for both therapy2,3 and diagnosis. With the development of monoclonal antibodies, much smaller targets can be used. An antibody to a given molecule may be directed only to part of

REFERENCES

Triplett DA, Brandt JT, Musgrave KA, et al:  The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA 1988;;259:550-554.
Simpson PJ, Todd RF, Santone JC, et al:  The reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti Mol, anti CD11B) that inhibits leukocyte adhesion. J Clin Invest , in press.
Ramsay N, Le Bien T, Nesbit M, et al:  Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: Results of bone marrow treated with monoclonal antibodies BA-1, BA-2 and BA-3, plus complement. Blood 1985;;66:508-513.
Polk BF, Fox R, Brookmayer R, et al:  Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987;;316:61-66.
Elias M, Eldor A:  Thromboembolism in patients with the 'lupus' type circulating anticoagulant. Arch Intern Med 1984;;144:510-517.
Feinstein DI:  Lupus anticoagulant, thrombosis, and fetal loss. N Engl J Med 1985;;312:1348-1350.
Alving BM, Banerji B, Fogler WE, et al:  Lupus anticoagulant activities of murine monoclonal antibodies to liposomal phosphatidylinositol phosphate. Clin Exp Immunol 1987;;69:403-408.
Lockshin MD, Qamar T, Druzin ML, et al:  Antibody to cardiolipin, lupus anticoagulant and fetal death. J Rheumatol 1987;:74:259-262.
Harris EN, Gharavi AE, Brey ML, et al:  Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;;2:1211-1214.
Alving BM, Baker CS:  Association of IgG cardiolipin antibody with thrombosis in patients with lupus anticoagulant, abstracted. Blood 1987;;70( (suppl 1) ):366A.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Triplett DA, Brandt JT, Musgrave KA, et al:  The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA 1988;;259:550-554.
Simpson PJ, Todd RF, Santone JC, et al:  The reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti Mol, anti CD11B) that inhibits leukocyte adhesion. J Clin Invest , in press.
Ramsay N, Le Bien T, Nesbit M, et al:  Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: Results of bone marrow treated with monoclonal antibodies BA-1, BA-2 and BA-3, plus complement. Blood 1985;;66:508-513.
Polk BF, Fox R, Brookmayer R, et al:  Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987;;316:61-66.
Elias M, Eldor A:  Thromboembolism in patients with the 'lupus' type circulating anticoagulant. Arch Intern Med 1984;;144:510-517.
Feinstein DI:  Lupus anticoagulant, thrombosis, and fetal loss. N Engl J Med 1985;;312:1348-1350.
Alving BM, Banerji B, Fogler WE, et al:  Lupus anticoagulant activities of murine monoclonal antibodies to liposomal phosphatidylinositol phosphate. Clin Exp Immunol 1987;;69:403-408.
Lockshin MD, Qamar T, Druzin ML, et al:  Antibody to cardiolipin, lupus anticoagulant and fetal death. J Rheumatol 1987;:74:259-262.
Harris EN, Gharavi AE, Brey ML, et al:  Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;;2:1211-1214.
Alving BM, Baker CS:  Association of IgG cardiolipin antibody with thrombosis in patients with lupus anticoagulant, abstracted. Blood 1987;;70( (suppl 1) ):366A.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.